PMID- 27942448 OWN - NLM STAT- MEDLINE DCOM- 20171117 LR - 20181113 IS - 2213-1582 (Electronic) IS - 2213-1582 (Linking) VI - 13 DP - 2017 TI - Brain connectivity aberrations in anabolic-androgenic steroid users. PG - 62-69 AB - Sustained anabolic-androgenic steroid (AAS) use has adverse behavioral consequences, including aggression, violence and impulsivity. Candidate mechanisms include disruptions of brain networks with high concentrations of androgen receptors and critically involved in emotional and cognitive regulation. Here, we tested the effects of AAS on resting-state functional brain connectivity in the largest sample of AAS-users to date. We collected resting-state functional magnetic resonance imaging (fMRI) data from 151 males engaged in heavy resistance strength training. 50 users tested positive for AAS based on the testosterone to epitestosterone (T/E) ratio and doping substances in urine. 16 previous users and 59 controls tested negative. We estimated brain network nodes and their time-series using ICA and dual regression and defined connectivity matrices as the between-node partial correlations. In line with the emotional and behavioral consequences of AAS, current users exhibited reduced functional connectivity between key nodes involved in emotional and cognitive regulation, in particular reduced connectivity between the amygdala and default-mode network (DMN) and between the dorsal attention network (DAN) and a frontal node encompassing the superior and inferior frontal gyri (SFG/IFG) and the anterior cingulate cortex (ACC), with further reductions as a function of dependency, lifetime exposure, and cycle state (on/off). FAU - Westlye, Lars T AU - Westlye LT AD - NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway; Department of Psychology, University of Oslo, Norway. FAU - Kaufmann, Tobias AU - Kaufmann T AD - NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway. FAU - Alnaes, Dag AU - Alnaes D AD - NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway. FAU - Hullstein, Ingunn R AU - Hullstein IR AD - Norwegian Doping Control Laboratory, Oslo University Hospital, Norway. FAU - Bjornebekk, Astrid AU - Bjornebekk A AD - Division of Mental Health and Addiction, Department on Substance Use Disorder Treatment, Norwegian National Advisory Unit on Substance Use Disorder Treatment, Oslo University Hospital, Norway. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20161117 PL - Netherlands TA - Neuroimage Clin JT - NeuroImage. Clinical JID - 101597070 RN - 0 (Anabolic Agents) RN - 0 (Androgens) SB - IM MH - Adult MH - *Amygdala/diagnostic imaging/drug effects/physiopathology MH - Anabolic Agents/*adverse effects MH - Androgens/*adverse effects MH - *Cerebral Cortex/diagnostic imaging/drug effects/physiopathology MH - *Connectome MH - Humans MH - Magnetic Resonance Imaging MH - *Nerve Net/diagnostic imaging/drug effects/physiopathology MH - Young Adult PMC - PMC5133655 OTO - NOTNLM OT - Amygdala OT - Anabolic-androgenic steroids (AAS) OT - Default-mode network OT - Dependency OT - Functional connectivity OT - fMRI EDAT- 2016/12/13 06:00 MHDA- 2017/11/29 06:00 PMCR- 2016/11/17 CRDT- 2016/12/13 06:00 PHST- 2016/09/20 00:00 [received] PHST- 2016/11/13 00:00 [revised] PHST- 2016/11/16 00:00 [accepted] PHST- 2016/12/13 06:00 [entrez] PHST- 2016/12/13 06:00 [pubmed] PHST- 2017/11/29 06:00 [medline] PHST- 2016/11/17 00:00 [pmc-release] AID - S2213-1582(16)30222-4 [pii] AID - 10.1016/j.nicl.2016.11.014 [doi] PST - epublish SO - Neuroimage Clin. 2016 Nov 17;13:62-69. doi: 10.1016/j.nicl.2016.11.014. eCollection 2017.